Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.98
-0.08-2.61%
At close: -
$2.98
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Protara Therapeutics Analyst Ratings and Price Targets | NASDAQ:TARA | Benzinga
Protara Therapeutics Inc has a consensus price target of $21 based on the ratings of 9 analysts. The high is $25 issued by Oppenheimer on August 12, 2024. The low is $12 issued by Scotiabank on April 16, 2025. The 3 most-recent analyst ratings were released by Jones Trading, HC Wainwright & Co., and Scotiabank on May 22, 2025, April 28, 2025, and April 16, 2025, respectively. With an average price target of $18.67 between Jones Trading, HC Wainwright & Co., and Scotiabank, there's an implied 526.40% upside for Protara Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jones Trading
HC Wainwright & Co.
Scotiabank
LifeSci Capital
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Protara Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/22/2025 | Buy Now | 604.7% | Jones Trading | Soumit Roy36% | → $21 | Initiates | → Buy | Get Alert |
| 04/28/2025 | Buy Now | 671.81% | HC Wainwright & Co. | Andres Maldonado47% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2025 | Buy Now | 302.68% | Scotiabank | George Farmer43% | → $12 | Initiates | → Sector Outperform | Get Alert |
| 03/14/2025 | Buy Now | — | Cantor Fitzgerald | Li Watsek42% | — | Initiates | → Overweight | Get Alert |
| 03/11/2025 | Buy Now | 638.26% | LifeSci Capital | — | → $22 | Initiates | → Outperform | Get Alert |
| 03/06/2025 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 12/06/2024 | Buy Now | 571.14% | Guggenheim | Michael Schmidt68% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 12/06/2024 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 738.93% | Oppenheimer | Leland Gershell69% | $30 → $25 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 05/06/2024 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 04/22/2024 | Buy Now | 906.71% | Oppenheimer | Leland Gershell69% | $26 → $30 | Maintains | Outperform | Get Alert |
| 04/08/2024 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $23 → $23 | Maintains | Buy | Get Alert |
| 03/14/2024 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 07/10/2023 | Buy Now | 638.26% | Guggenheim | Charles Zhu64% | → $22 | Assumes | → Buy | Get Alert |
| 05/08/2023 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | → $23 | Reiterates | → Buy | Get Alert |
| 05/01/2023 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | → $23 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | → $23 | Reiterates | → Buy | Get Alert |
| 08/10/2022 | Buy Now | 671.81% | HC Wainwright & Co. | Andrew Fein61% | $30 → $23 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Protara Therapeutics (TARA) stock?
The latest price target for Protara Therapeutics (NASDAQ:TARA) was reported by Jones Trading on May 22, 2025. The analyst firm set a price target for $21.00 expecting TARA to rise to within 12 months (a possible 604.70% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Protara Therapeutics (TARA)?
The latest analyst rating for Protara Therapeutics (NASDAQ:TARA) was provided by Jones Trading, and Protara Therapeutics initiated their buy rating.
When was the last upgrade for Protara Therapeutics (TARA)?
There is no last upgrade for Protara Therapeutics
When was the last downgrade for Protara Therapeutics (TARA)?
There is no last downgrade for Protara Therapeutics.
When is the next analyst rating going to be posted or updated for Protara Therapeutics (TARA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Protara Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Protara Therapeutics was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
Is the Analyst Rating Protara Therapeutics (TARA) correct?
While ratings are subjective and will change, the latest Protara Therapeutics (TARA) rating was a initiated with a price target of $0.00 to $21.00. The current price Protara Therapeutics (TARA) is trading at is $2.98, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
